The corporate’s income from operations rose to Rs 1,851 crore for the quarter into consideration, up 7.81 per cent, as towards Rs 1,716.Eight crore throughout the identical interval a yr in the past, Biocon stated in a late evening regulatory submitting on Thursday.
Bills rose to Rs 1,642.6 crore for the December quarter, a rise of 14.52 per cent, as towards Rs 1,434.three crore within the year-ago interval.
Kiran Mazumdar-Shaw, Government Chairperson, Biocon, stated: “2020 has been probably the most difficult years for the world with an unprecedented pandemic impression on the worldwide economic system. We proceed to face headwinds throughout operational, regulatory and industrial capabilities which have been deterrents to our deliberate market growth. Nevertheless, we count on normalisation by subsequent fiscal”.
Shares of Biocon Ltd had been buying and selling 8.44 per cent decrease at Rs 404.64 apiece on the BSE.